Lauren Dubinsky

New York

Medtech Reporter at Modern Healthcare

Featured in: Favicon

dotmed.com Favicon

modernhealthcare.com Favicon

chicagobusiness.com Favicon

crainsdetroit.com Favicon

crainscleveland.com Favicon

crainsnewyork.com

Articles

How Providence, Duke are navigating AI regulation without feds

1 week ago | modernhealthcare.com | Brock Turner |Nona Tepper |Lauren Dubinsky |Michael McAuliff

There is currently a lack of AI comprehensive federal regulation.
Medtronic names new diabetes company MiniMed

2 weeks ago | modernhealthcare.com | Lauren Dubinsky

Medtronic plans to separate its diabetes unit within 18 months, aiming to focus on high-margin growth markets.
Abbott to pair glucose-ketone sensor with Tandem's insulin pumps

2 weeks ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Digital Health June 10, 2025 03:19 PM Tweet Share Share Email More Reprints Print Tandem Diabetes Care Tandem Diabetes Care's t:slim X2 insulin pump. Abbott and Tandem Diabetes Care announced Tuesday an agreement to combine Abbott’s upcoming dual glucose-ketone sensor with Tandem's insulin delivery systems to create integrated diabetes solutions.
Biosense Webster must pay triple damages in antitrust lawsuit

2 weeks ago | crainsnewyork.com | Lauren Dubinsky

U.S. District Court Judge James Selna in California has tripled the damages to $442 million in a case where a jury found Johnson & Johnson’s medical technology unit Biosense Webster had violated antitrust laws. On May 16, a jury found Biosense Webster guilty of withholding clinical support from hospitals that purchased reprocessed catheters from Innovative Health, and ordered the company to pay $147 million in damages.
Biosense Webster must pay triple damages in antitrust lawsuit

3 weeks ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Digital Health June 06, 2025 04:15 PM Tweet Share Share Email More Reprints Print Modern Healthcare Illustration / Getty Images U.S. District Court Judge James Selna in California has tripled the damages to $442 million in a case where a jury found Johnson & Johnson’s medical technology unit Biosense Webster had violated antitrust laws.
Vantive, Baxter's former kidney care unit, to invest $1B in tech

3 weeks ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Digital Health June 02, 2025 03:11 PM Tweet Share Share Email More Reprints Print Google Street View 510 Lake Cook Road, Deerfield, IL Vantive, Baxter International’s former kidney care segment, announced Monday it plans to invest more than $1 billion in new technology over the next five years.
Paradromics, Neuralink race for FDA approval in BCI market

4 weeks ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Digital Health June 02, 2025 07:00 AM Tweet Share Share Email More Reprints Print University of Michigan Dr. Matthew Willsey preparing the Connexus Brain-Computer Interface to be implanted into the first patient.
Connected care barriers divide providers, medtech executives

1 month ago | modernhealthcare.com | Lauren Dubinsky |Tim Broderick

Breadcrumb Home Digital Health May 27, 2025 11:00 PM Tweet Share Share Email More Reprints Print AdobeStock Medtech leaders misunderstand the main barriers providers face in adopting connected care devices such as robotic surgery systems, imaging machines and bed sensors, according to a new survey.
Augmented reality headsets offer alternative to robotic systems

1 month ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Digital Health May 27, 2025 05:00 AM Tweet Share Share Email More Reprints Print UC Davis Health Dr. Edward Strong using the augmented reality headset during a surgery. Major health systems are turning to augmented reality headsets to make surgery more efficient and more precise while reducing costs.
J&J's Biosense Webster ordered to pay $147M in antitrust lawsuit

1 month ago | modernhealthcare.com | Lauren Dubinsky

Breadcrumb Home Legal May 19, 2025 11:38 AM Tweet Share Share Email More Reprints Print Adobe Stock A California federal jury ordered Johnson & Johnson’s medical technology unit Biosense Webster to pay $147 million after finding it violated federal and state antitrust laws by refusing to provide clinical support to hospitals that used third-party reprocessed catheters.